Moore Capital Management, LP Karyopharm Therapeutics Inc. Transaction History

Moore Capital Management, LP

  • $5.25 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$4.32 - $6.43 $432,000 - $643,000
-100,000 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$17.03 - $21.18 $851,500 - $1.06 Million
-50,000 Reduced 33.33%
100,000 $1.7 Million
Q2 2018

Aug 14, 2018
BUY
$12.0 - $19.88 $1.8 Million - $2.98 Million
150,000 New
150,000 $2.55 Million

Others Institutions Holding KPTI

# of Institutions
115
Shares Held
65.3M
Call Options Held
500K
Put Options Held
99K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $71M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email